Value proposition development for a phase 3 neuroscience asset

• Life Sciences
• CRA Insights

100 days. 14 executive orders. Some bold healthcare policies.

In this CRA Insights, we assess the actions and impact of the second Trump Administration during the first 100 days that directly affect healthcare policy,...

• Life Sciences
• Articles

Asembia AXS25: Becky Davis on GLP-1s

CRA consultant Becky Davis was interviewed at Asembia AXS25 Summit to highlight her presentation titled “GLP-1s: Riding the Wave of Innovative Medications.”

• Life Sciences
• Sponsorship & Speaking Engagement

• July 30-31, 2025
• Boston, MA

ACI 12th Annual Summit for Women Leaders in Life Sciences Law

CRA is a proud sponsor of the conference that aims to increase the prominence of women through professional development, substantive legal discussion, and...

• Intellectual Property
• Sponsorship & Speaking Engagement

• October 27-29, 2025
• Ashburn, VA

IP Watchdog: 4th Annual Life Sciences Masters™ 2025

CRA is a proud sponsor of the conference focusing on the intersection of intellectual property and the biopharmaceutical industry, and will explore the law,...